
Alpha Profiles · Company Profile
LEXICON PHARMACEUTICALS, INC.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/lexicon-pharmaceuticals-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: LXRX
- Verification
- Partially verified
- Last reviewed
- 2026-10-12T02:56:29.077205+00:00
Overview
Alpha's canonical identity and public leadership record for LEXICON PHARMACEUTICALS, INC..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
8 public recordsSenior Vice President and General Counsel
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- LXRX 10-K executive officersMar 5, 2026
Senior Vice President and Chief Medical Officer
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- LXRX 10-K executive officersMar 5, 2026
Senior Vice President, Investor Relations and Corporate Communications
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- LXRX 10-K executive officersMar 5, 2026
Chief Executive Officer and Director
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- LXRX 10-K executive officersMar 5, 2026
Senior Vice President, Partnerships and Corporate Strategy
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- LXRX 10-K executive officersMar 5, 2026
Senior Vice President and Chief Financial Officer
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- LXRX 10-K executive officersMar 5, 2026
Senior Vice President, Discovery
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- LXRX 10-K executive officersMar 5, 2026

Senior Vice President, Human Resources
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- LXRX 10-K executive officersMar 5, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 12, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
7 public records- State
- confirmed
- Effective
- From Jan 1, 2007
- Confidence
- 85%
- Evidence
- LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16Mar 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 85%
- Evidence
- LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16Mar 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 85%
- Evidence
- LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16Mar 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 85%
- Evidence
- LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16Mar 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2007
- Confidence
- 85%
- Evidence
- LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16Mar 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2007
- Confidence
- 85%
- Evidence
- LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16Mar 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2000
- Confidence
- 85%
- Evidence
- LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16Mar 16, 2026
Committees
2 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Not stated
- Members
- Diane E. Sullivan; Ivan H. Cheung
Compensation
- Chair
- Not stated
- Members
- Philippe J. Amouyal
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-12T02:56:29.077205+00:00
